"Zinc Containing Vaginal Topical Suppository "

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 30, 2022

Conditions

Genitourinary Syndrome of Menopause

Interventions

DRUG

Zinc

To test the effect of a novel zinc-containing vaginal topical on GSM/VVA symptoms.

Trial Locations (1)

Al-Azhar University Hospitals and Ashmoun central hospital, Cairo

All Listed Sponsors

lead

Egymedicalpedia

INDUSTRY

NCT05453227 - "Zinc Containing Vaginal Topical Suppository " | Biotech Hunter | Biotech Hunter